If we expand our presence outside of the United States, it will require us to dedicate additional resources to comply with these laws, and these laws may preclude us from developing, manufacturing, or selling certain products and product candidates outside of the United States, which could limit our growth potential and increase our development costs.

filing / Jul 30, 2026 / receipt

The Company's restricted cash balance, which is classified within prepaid expenses and other current assets and other assets on the condensed consolidated balance sheets, consists of letters of credit related to leased and subleased office space in Watertown, Massachusetts.

filing / Jul 30, 2026 / receipt

The continuing efforts of the government, insurance companies, managed care organizations and other payors of healthcare services to contain or reduce costs of healthcare and/or impose price controls may adversely affect the demand for our current or future product candidates, if we obtain regulatory approval; our ability to set a price that we believe is fair for our products; our ability to obtain coverage and reim

filing / Jul 30, 2026 / receipt

If we are unable to realize the expected operational efficiencies and cost savings from this restructuring, our operating results and financial condition would be adversely affected.

filing / Jul 30, 2026 / receipt

If we expand our presence outside of the United States, it will require us to dedicate additional 69 resources to comply with these laws, and these laws may preclude us from developing, manufacturing, or selling certain products and product candidates outside of the United States, which could limit our growth potential and increase our development costs.

filing / May 5, 2026 / receipt

The Company's restricted cash balance, which is classified within prepaid expenses and other current assets and other assets on the condensed consolidated balance sheets, consists of letters of credit related to leased and subleased office space in Watertown, Massachusetts.

filing / May 5, 2026 / receipt

The continuing efforts of the government, insurance companies, managed care organizations and other payors of healthcare services to contain or reduce costs of healthcare and/or impose price controls may adversely affect the demand for our current or future product candidates, if we obtain regulatory approval; our ability to set a price that we believe is fair for our products; our ability to obtain coverage and reim

filing / May 5, 2026 / receipt

If we are unable to realize the expected operational efficiencies and cost savings from this restructuring, our operating results and financial condition would be adversely affected.

filing / May 5, 2026 / receipt

Associate Director, Bioanalytical | {"ats": "greenhouse", "city": null, "state": null, "job_id": "5418625008", "remote": false, "category": "other", "function": "retail", "location": "Massachusetts -

company_statement / Sep 14, 2026 / receipt

Director, Legal and Compliance | {"ats": "greenhouse", "city": null, "state": null, "job_id": "5419488008", "remote": false, "category": "other", "function": "legal", "location": "Massachusetts - Hybr

company_statement / Sep 11, 2026 / receipt

Medical Director, Clinical Development | {"ats": "greenhouse", "city": null, "state": null, "job_id": "5394244008", "remote": false, "category": "other", "function": "clinical", "location": "Massachus

company_statement / Sep 1, 2026 / receipt

Senior Director, Toxicology | {"ats": "greenhouse", "city": null, "state": null, "job_id": "5405618008", "remote": false, "category": "other", "function": "other", "location": "Massachusetts - Hybrid"

company_statement / Aug 31, 2026 / receipt